CVS wants payback from GMP violators; Genzyme sued for Fabrazyme rationing;

> CVS Pharmacy is demanding $100 million from KV Pharmaceutical, Ethex and Nesher Pharmaceuticals for halting the supply of generics in 2008 due to GMP failures. News

> Fabry disease sufferers have filed suit against Genzyme and Mt. Sinai Medical School, the developer and license holder of Fabrazyme, for their handling of the drug shortage. Story

> Regional drug-production hubs created via big pharma tech transfer can improve public health and drive economic development in low- to mid-income countries, says Eli Lilly. Article

> Sanofi has recalled nearly 200,000 doses of the ActHIB flu vaccine in Japan; users found foreign matter in the syringes after injection. Story

> Amgen will buy a Pfizer manufacturing plant at Dun Laoghaire, County Dublin, securing 280 jobs. Release

> In response to a new healthcare reform reimbursement policy, doctors are balking at writing prescriptions for OTC products and pharmacists are complaining about filling them. Item